CURRENT REPORT

Company

Lantern Pharma Inc.

Filed

May 25, 2021

Period of Report

May 19, 2021

Accession Number

0001213900-21-028984

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →